Compass Pathways Plc ADR (CMPS)

$5.58 -0.14 (-2.45%)
Market Cap 531.93M
Revenue (ttm) 0.00
Net Income (ttm) -287.86M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio -0.60
Volume 1,208,700
Avg Vol 3,196,398
Day's Range N/A - N/A
Shares Out 96.02M
Stochastic %K 79%
Beta 2.01
Analysts Strong Sell
Price Target $21.83

Company Profile

COMPASS Pathways plc operates as a biotechnology company that focuses on mental health in the United Kingdom and the United States. It develops COMP360, a psilocybin therapy, which is in Phase III clinical trial for the treatment of treatment-resistant depression; and is in Phase II clinical trial for treating post-traumatic stress disorder and anorexia nervosa. The company was formerly known as COMPASS Rx Limited and changed its name to COMPASS Pathways plc in August 2020. The company was incor...

Industry: Medical Care Facilities
Sector: Healthcare
Address:
33 Broadwick Street, London, United Kingdom
FBP
FBP Apr. 9 at 9:08 PM
$CMPS she’s fine she’s fine
0 · Reply
Apes_Strong
Apes_Strong Apr. 9 at 8:02 PM
$CMPS trash 😡 💩
0 · Reply
BobJohnBuoy666
BobJohnBuoy666 Apr. 9 at 5:31 PM
$CMPS bullish triangle setup
1 · Reply
Apes_Strong
Apes_Strong Apr. 9 at 4:58 PM
$CMPS 400,000 shares at 6.29 this POS 💩is antagonising me to sell just so it can spike after that
0 · Reply
RarelyRight
RarelyRight Apr. 9 at 4:37 PM
$DFTX I don’t get why this has run 50%+ in the last 3 months while every other psychedelic stock has been flat to down. Do I sell some and move it to $ATAI or $CMPS ?
3 · Reply
Apes_Strong
Apes_Strong Apr. 9 at 2:20 PM
$CMPS what is wrong with this 💩
1 · Reply
Sailingsoon
Sailingsoon Apr. 9 at 6:59 AM
$CMPS sails are set the course is right and the wind upcoming is increasing https://ir.compasspathways.com/News--Events-/news/news-details/2026/Compass-Pathways-Announces-New-Employee-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635c4/default.aspx I love steady strong Passat winds
0 · Reply
cacci11
cacci11 Apr. 8 at 10:28 PM
$CMPS like a pimple about to pop
2 · Reply
Sailingsoon
Sailingsoon Apr. 8 at 6:12 PM
$CMPS Interesting overview https://psychedelicalpha.com/resources/psychedelic-readout-tracker/
0 · Reply
Millionaire11
Millionaire11 Apr. 8 at 12:38 AM
$CMPS never thought this would be affected so much by geopolitics
0 · Reply
Latest News on CMPS
Compass Pathways to Attend Needham Virtual Healthcare Conference on April 14, 2026

Apr 8, 2026, 6:30 AM EDT - 1 day ago

Compass Pathways to Attend Needham Virtual Healthcare Conference on April 14, 2026

Compass Pathways Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Apr 7, 2026, 4:30 PM EDT - 2 days ago

Compass Pathways Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Compass Pathways Announces Fourth Quarter and Full-Year 2025 Financial Results and Business Highlights

Mar 24, 2026, 7:30 AM EDT - 16 days ago

Compass Pathways Announces Fourth Quarter and Full-Year 2025 Financial Results and Business Highlights

Compass Pathways to Present at Stifel 2026 Virtual CNS Forum on March 18, 2026

Mar 12, 2026, 6:30 AM EDT - 4 weeks ago

Compass Pathways to Present at Stifel 2026 Virtual CNS Forum on March 18, 2026

Compass Pathways Announces Exercise of $200 Million in Outstanding Warrants

Feb 26, 2026, 6:30 AM EST - 6 weeks ago

Compass Pathways Announces Exercise of $200 Million in Outstanding Warrants

Compass Pathways to attend TD Cowen 46th Annual Healthcare Conference in Boston, MA from March 2-4, 2026

Feb 24, 2026, 6:39 AM EST - 6 weeks ago

Compass Pathways to attend TD Cowen 46th Annual Healthcare Conference in Boston, MA from March 2-4, 2026

Compass Pathways Announces Pricing of $150 Million Public Offering

Feb 18, 2026, 8:18 PM EST - 7 weeks ago

Compass Pathways Announces Pricing of $150 Million Public Offering

Compass Pathways Launches Proposed $150.0 Million Public Offering

Feb 17, 2026, 4:06 PM EST - 7 weeks ago

Compass Pathways Launches Proposed $150.0 Million Public Offering

Compass Pathways' depression treatment meets main goal in late‑stage study

Feb 17, 2026, 6:42 AM EST - 7 weeks ago

Compass Pathways' depression treatment meets main goal in late‑stage study

Compass Pathways Successfully Achieves Primary Endpoint in Second Phase 3 Trial Evaluating COMP360 Psilocybin for Treatment-Resistant Depression

Feb 17, 2026, 6:30 AM EST - 7 weeks ago

Compass Pathways Successfully Achieves Primary Endpoint in Second Phase 3 Trial Evaluating COMP360 Psilocybin for Treatment-Resistant Depression

Compass Pathways to Announce New Clinical Data from Two Ongoing Phase 3 Trials

Feb 16, 2026, 8:00 AM EST - 7 weeks ago

Compass Pathways to Announce New Clinical Data from Two Ongoing Phase 3 Trials

COMPASS Pathways Plc ADR (CMPS) Price Forecast: Bullish Reversal Gains Structure

Feb 9, 2026, 5:01 PM EST - 2 months ago

COMPASS Pathways Plc ADR (CMPS) Price Forecast: Bullish Reversal Gains Structure

Compass Pathways Announces FDA Acceptance of IND Application for PTSD and Hosts Webinar on PTSD and TRD

Jan 7, 2026, 6:30 AM EST - 3 months ago

Compass Pathways Announces FDA Acceptance of IND Application for PTSD and Hosts Webinar on PTSD and TRD

Compass Pathways Establishes Strategic Collaboration with Radial to Innovate Patient Experience and Inform Potential Delivery Model of COMP360

Jan 6, 2026, 6:30 AM EST - 3 months ago

Compass Pathways Establishes Strategic Collaboration with Radial to Innovate Patient Experience and Inform Potential Delivery Model of COMP360

Compass Pathways to Host Webinar on Commercial Preparations for Treatment-Resistant Depression (TRD) and Clinical Trial Plans for Post-Traumatic Stress Disorder (PTSD) on January 7, 2026, 10:00am ET

Dec 9, 2025, 6:30 AM EST - 4 months ago

Compass Pathways to Host Webinar on Commercial Preparations for Treatment-Resistant Depression (TRD) and Clinical Trial Plans for Post-Traumatic Stress Disorder (PTSD) on January 7, 2026, 10:00am ET

Compass Pathways to Participate in Two Investor Conferences in December

Nov 20, 2025, 6:30 AM EST - 5 months ago

Compass Pathways to Participate in Two Investor Conferences in December

Compass Pathways to Participate in Stifel 2025 Healthcare Conference

Nov 5, 2025, 6:30 AM EST - 5 months ago

Compass Pathways to Participate in Stifel 2025 Healthcare Conference

Compass Pathways to expedite launch timing of its experimental depression therapy

Nov 4, 2025, 6:45 AM EST - 5 months ago

Compass Pathways to expedite launch timing of its experimental depression therapy

Compass Pathways Announces Third Quarter 2025 Financial Results and Business Highlights Including Acceleration of Commercial Launch Plans by 9-12 Months

Nov 4, 2025, 6:30 AM EST - 5 months ago

Compass Pathways Announces Third Quarter 2025 Financial Results and Business Highlights Including Acceleration of Commercial Launch Plans by 9-12 Months

NeuroKaire Enters into R&D Collaboration with Compass Pathways to Pioneer Precision Treatments for Depression

Oct 30, 2025, 8:30 AM EDT - 5 months ago

NeuroKaire Enters into R&D Collaboration with Compass Pathways to Pioneer Precision Treatments for Depression

Compass Pathways Appoints Dr. Jeffrey Jonas to Board of Directors

Oct 29, 2025, 6:30 AM EDT - 5 months ago

Compass Pathways Appoints Dr. Jeffrey Jonas to Board of Directors

Compass Pathways to Announce Third Quarter Financial Results on November 4, 2025

Oct 28, 2025, 6:30 AM EDT - 5 months ago

Compass Pathways to Announce Third Quarter Financial Results on November 4, 2025

Compass Pathways Announces Publication of Results from Phase 2 Study of COMP360 Psilocybin for Post-Traumatic Stress Disorder

Sep 2, 2025, 6:30 AM EDT - 7 months ago

Compass Pathways Announces Publication of Results from Phase 2 Study of COMP360 Psilocybin for Post-Traumatic Stress Disorder

Compass Pathways to Participate in Four Investor Conferences in September

Aug 27, 2025, 6:30 AM EDT - 8 months ago

Compass Pathways to Participate in Four Investor Conferences in September

Compass Pathways to Participate in Canaccord Genuity 45th Annual Growth Conference on August 12, 2025 in Boston, MA

Aug 5, 2025, 6:30 AM EDT - 8 months ago

Compass Pathways to Participate in Canaccord Genuity 45th Annual Growth Conference on August 12, 2025 in Boston, MA

Compass Pathways Announces Second Quarter 2025 Financial Results and Business Highlights

Jul 31, 2025, 6:30 AM EDT - 9 months ago

Compass Pathways Announces Second Quarter 2025 Financial Results and Business Highlights

Compass Pathways Appoints Justin Gover to Board of Directors

Jul 29, 2025, 6:30 AM EDT - 9 months ago

Compass Pathways Appoints Justin Gover to Board of Directors

Compass Pathways to Announce Second Quarter Financial Results on July 31, 2025

Jul 22, 2025, 6:30 AM EDT - 9 months ago

Compass Pathways to Announce Second Quarter Financial Results on July 31, 2025

Compass Pathways to Participate in HC Wainwright @Home Series Interview on July 14th, 8:00am ET

Jul 10, 2025, 4:00 PM EDT - 9 months ago

Compass Pathways to Participate in HC Wainwright @Home Series Interview on July 14th, 8:00am ET

Vizsla Silver, COMPASS Pathways And Other Big Stocks Moving Lower In Monday's Pre-Market Session

Jun 23, 2025, 8:25 AM EDT - 10 months ago

Vizsla Silver, COMPASS Pathways And Other Big Stocks Moving Lower In Monday's Pre-Market Session

VZLA

Compass Pathways stock slip as psilocybin depression trial falls short of expectations

Jun 23, 2025, 8:12 AM EDT - 10 months ago

Compass Pathways stock slip as psilocybin depression trial falls short of expectations

Compass Pathways' depression drug succeeds late-stage trial

Jun 23, 2025, 6:48 AM EDT - 10 months ago

Compass Pathways' depression drug succeeds late-stage trial

Compass Pathways Successfully Achieves Primary Endpoint in First Phase 3 Trial Evaluating COMP360 Psilocybin for Treatment-Resistant Depression

Jun 23, 2025, 6:30 AM EDT - 10 months ago

Compass Pathways Successfully Achieves Primary Endpoint in First Phase 3 Trial Evaluating COMP360 Psilocybin for Treatment-Resistant Depression

Compass Pathways to Participate in 2025 RBC Capital Markets Global Healthcare Conference

May 14, 2025, 6:30 AM EDT - 11 months ago

Compass Pathways to Participate in 2025 RBC Capital Markets Global Healthcare Conference

Compass Pathways Announces First Quarter 2025 Financial Results and Business Highlights

May 8, 2025, 6:30 AM EDT - 1 year ago

Compass Pathways Announces First Quarter 2025 Financial Results and Business Highlights

Compass Pathways Establishes Strategic Collaboration with HealthPort to Inform the Potential Delivery of COMP360 Synthesized Psilocybin Treatment in Underserved Communities

Apr 29, 2025, 6:30 AM EDT - 1 year ago

Compass Pathways Establishes Strategic Collaboration with HealthPort to Inform the Potential Delivery of COMP360 Synthesized Psilocybin Treatment in Underserved Communities

Compass Pathways to Announce First Quarter Financial Results on May 8, 2025

Apr 28, 2025, 6:30 AM EDT - 1 year ago

Compass Pathways to Announce First Quarter Financial Results on May 8, 2025

Compass Pathways Announces Dosing Complete for All Participants in Part A of Phase 3 COMP005 Trial of COMP360 Psilocybin for Treatment-Resistant Depression

Apr 22, 2025, 6:00 AM EDT - 1 year ago

Compass Pathways Announces Dosing Complete for All Participants in Part A of Phase 3 COMP005 Trial of COMP360 Psilocybin for Treatment-Resistant Depression

This Is a Test From GlobeNewswire

Mar 28, 2025, 5:01 PM EDT - 1 year ago

This Is a Test From GlobeNewswire

ALVO

Compass Pathways Announces Completion of Recruitment for the Phase 3 COMP005 Trial of COMP360 Psilocybin for Treatment-Resistant Depression

Mar 26, 2025, 6:30 AM EDT - 1 year ago

Compass Pathways Announces Completion of Recruitment for the Phase 3 COMP005 Trial of COMP360 Psilocybin for Treatment-Resistant Depression

Compass Pathways Announces Publication of Results from COMP004 Study on COMP360 Psilocybin for Treatment-Resistant Depression

Mar 18, 2025, 6:30 AM EDT - 1 year ago

Compass Pathways Announces Publication of Results from COMP004 Study on COMP360 Psilocybin for Treatment-Resistant Depression

Compass Pathways to Participate in Stifel Virtual CNS Forum

Mar 11, 2025, 6:30 AM EDT - 1 year ago

Compass Pathways to Participate in Stifel Virtual CNS Forum

Psychedelics-Focused Compass Pathways Has Established Itself As 'Credible CNS Biotechnology Company,' Analyst Says

Feb 27, 2025, 4:02 PM EST - 1 year ago

Psychedelics-Focused Compass Pathways Has Established Itself As 'Credible CNS Biotechnology Company,' Analyst Says

Compass Pathways Announces Fourth Quarter and Full-Year 2024 Financial Results and Business Highlights

Feb 27, 2025, 6:30 AM EST - 1 year ago

Compass Pathways Announces Fourth Quarter and Full-Year 2024 Financial Results and Business Highlights

Compass Pathways to Participate in TD Cowen 45th Annual Health Care Conference

Feb 25, 2025, 4:00 PM EST - 1 year ago

Compass Pathways to Participate in TD Cowen 45th Annual Health Care Conference

Compass Pathways to announce fourth quarter and year-end financial results on February 27th, 2025

Feb 18, 2025, 6:30 AM EST - 1 year ago

Compass Pathways to announce fourth quarter and year-end financial results on February 27th, 2025

Compass Pathways to Participate in Oppenheimer 35th Annual Healthcare Life Sciences Conference

Feb 5, 2025, 6:30 AM EST - 1 year ago

Compass Pathways to Participate in Oppenheimer 35th Annual Healthcare Life Sciences Conference

Compass Pathways Appoints Steve Levine, M.D., as Chief Patient Officer

Jan 21, 2025, 6:30 AM EST - 1 year ago

Compass Pathways Appoints Steve Levine, M.D., as Chief Patient Officer

Compass Pathways Announces Pricing of Underwritten Offering

Jan 10, 2025, 7:01 AM EST - 1 year ago

Compass Pathways Announces Pricing of Underwritten Offering

Compass Pathways to Be Added to the NASDAQ Biotechnology Index (NBI)

Dec 18, 2024, 6:30 AM EST - 1 year ago

Compass Pathways to Be Added to the NASDAQ Biotechnology Index (NBI)

FBP
FBP Apr. 9 at 9:08 PM
$CMPS she’s fine she’s fine
0 · Reply
Apes_Strong
Apes_Strong Apr. 9 at 8:02 PM
$CMPS trash 😡 💩
0 · Reply
BobJohnBuoy666
BobJohnBuoy666 Apr. 9 at 5:31 PM
$CMPS bullish triangle setup
1 · Reply
Apes_Strong
Apes_Strong Apr. 9 at 4:58 PM
$CMPS 400,000 shares at 6.29 this POS 💩is antagonising me to sell just so it can spike after that
0 · Reply
RarelyRight
RarelyRight Apr. 9 at 4:37 PM
$DFTX I don’t get why this has run 50%+ in the last 3 months while every other psychedelic stock has been flat to down. Do I sell some and move it to $ATAI or $CMPS ?
3 · Reply
Apes_Strong
Apes_Strong Apr. 9 at 2:20 PM
$CMPS what is wrong with this 💩
1 · Reply
Sailingsoon
Sailingsoon Apr. 9 at 6:59 AM
$CMPS sails are set the course is right and the wind upcoming is increasing https://ir.compasspathways.com/News--Events-/news/news-details/2026/Compass-Pathways-Announces-New-Employee-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635c4/default.aspx I love steady strong Passat winds
0 · Reply
cacci11
cacci11 Apr. 8 at 10:28 PM
$CMPS like a pimple about to pop
2 · Reply
Sailingsoon
Sailingsoon Apr. 8 at 6:12 PM
$CMPS Interesting overview https://psychedelicalpha.com/resources/psychedelic-readout-tracker/
0 · Reply
Millionaire11
Millionaire11 Apr. 8 at 12:38 AM
$CMPS never thought this would be affected so much by geopolitics
0 · Reply
Millionaire11
Millionaire11 Apr. 7 at 11:18 PM
$CMPS why is this up after hours?
1 · Reply
Sauce27x
Sauce27x Apr. 7 at 4:47 PM
$CMPS FUCK
0 · Reply
BobJohnBuoy666
BobJohnBuoy666 Apr. 7 at 4:25 PM
$CMPS sticking with this call
0 · Reply
BankOnTheFuture
BankOnTheFuture Apr. 7 at 4:15 PM
$CMPS https://www.military.com/daily-news/2026/04/06/major-step-new-law-would-prep-va-fda-approved-psychedelic-treatments.html
1 · Reply
Sailingsoon
Sailingsoon Apr. 6 at 1:50 PM
$CMPS
0 · Reply
Apes_Strong
Apes_Strong Apr. 6 at 12:35 PM
$CMPS this is a great article for CMPS
0 · Reply
BankOnTheFuture
BankOnTheFuture Apr. 3 at 7:11 PM
$CMPS Writeup in Investors Business Daily. "Compass Pathways is poised to play a critical role in pushing psychedelic drugs into the mainstream. The U.K.-based company is the closest to a potential FDA approval — possibly later this year or early next." https://www.investors.com/news/technology/psychedelic-drugs-rfk-jr-depression-ptsd-anxiety-veterans/
0 · Reply
LoadedUP1000
LoadedUP1000 Apr. 2 at 11:30 PM
$ATAI $CMPS $DFTX $GHRS $HELP Exactly!!! I think most people missed this news. Locked and loaded!
1 · Reply
LoadedUP1000
LoadedUP1000 Apr. 2 at 11:28 PM
$CMPS Big Opportunity here folks. Don’t sleep on it. Multi Billion news very soon. Game changer for the world.
0 · Reply
ClownThePoet
ClownThePoet Apr. 2 at 7:46 PM
$CMPS anyone worried about the high volume dump last month. looks like the same volume that entered at 2$ exited at 9$
0 · Reply
Apes_Strong
Apes_Strong Apr. 2 at 7:45 PM
$CMPS what a dead board Billion dollar biotech with 400 mil cash, 2 stat sig p3 trials completed, and some of the most prolific fund managers in the name, and no one here What a waste
1 · Reply
Sibtsen
Sibtsen Apr. 2 at 2:57 PM
$ATAI $CMPS Last weekend, I used mushrooms with someone who was pretty skeptical about psychedelics. He ended up taking a larger dose than usual because he felt a (calling) to explore deeper parts of himself. He experienced being part of something much greater than himself. Now, he finally understands why I use this for self healing. It completely changed his perspective, and he now sees how people stuck in deep patterns can truly transform in just one or two sessions. I believe in this now more then ever! Bought some more shares today!
2 · Reply